Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device

NCT03925324 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Lack of funding/Covid-19

Conditions

Ischemic Heart Disease
Non-ischemic Cardiomyopathy

Interventions

BIOLOGICAL: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)
OTHER: Placebo

Sponsor

Medstar Health Research Institute